102 Chapter 6 References 1. Oronsky, B., Reid, T., Larson, C., & Knox, S. J. (2020). Locally advanced rectal cancer: The past, present, and future. Semin Oncol 47(1), 85–92. 2. van der Valk MJM, Hilling DE, Bastiaannet E, et al.(2018) Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. Lancet 391(10139), 2537– 2545 3. Lambregts, D., Boellaard, T. N., & Beets-Tan, R. (2019). Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review. Insights Imaging 10(1), 15. 4. Barbaro B, Vitale R, Leccisotti L, et al. (2010). Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. Radiographics 30(3), 699–716. 5. Mandard AM, Dalibard F, Mandard JC, et al. (1994). Pathologic assessment of tumour regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73(11), 2680–2686.tumour 6. Siddiqui MR, Gormly KL, Bhoday J, et al. (2016). Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). Clin Radiol 71(9), 854–862. 7. Jang JK, Choi SH, Park SH, et al. (2020). MR tumour regression grade for pathological complete response in rectal cancer post neoadjuvant chemoradiotherapy: a systematic review and meta-analysis for accuracy. Eur Radiol 30(4), 2312–2323.tumour 8. Bhoday J, Smith F, Siddiqui MR, et al. (2016). Magnetic Resonance Tumour Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy. Dis Colon Rectum 59(10), 925–933.Tumour 9. Patel UB, Brown G, Rutten H, et al. (2012). Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer. Ann Surg Oncol 19(9), 2842–2852. 10. Lee MA, Cho SH, Seo AN, et al. (2017). Modified 3-Point MRI-Based Tumour Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer. AJR Am J Roentgenol 209(6), 1247–1255. Tumour 11. Haak HE, Maas M, Lahaye MJ, et al. (2020). Selection of Patients for Organ Preservation After Chemoradiotherapy: MRI Identifies Poor Responders Who Can Go Straight to Surgery. Ann Surg Oncol 27(8), 2732–2739. 12. Schurink, N. W., Lambregts, D., & Beets-Tan, R. (2019). Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol 92(1096), 20180655. 13. Lambregts DMJ, Delli Pizzi A, Lahaye MJ, et al. (2018). A Pattern-Based Approach Combining Tumour Morphology on MRI With Distinct Signal Patterns on Diffusion-Weighted Imaging to Assess Response of Rectal Tumours After Chemoradiotherapy. Dis Colon Rectum 61(3), 328– 337. TumourTumour 14. Santiago I, Barata M, Figueiredo N, et al. (2020). The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer. Eur Radiol 30(1), 224–238. 15. Gormly K. (2021). Rectal MRI: the importance of high resolution T2 technique. Abdom Radiol (NY) 46(9), 4090–4095. 16. Beets-Tan RGH, Lambregts DMJ, Maas M, et al. (2018). Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28(4), 1465–1475. 17. van Griethuysen JJM, Bus EM, Hauptmann M, et al. (2018). Gas-induced susceptibility artefacts on diffusion-weighted MRI of the rectum at 1.5 T - Effect of applying a micro-enema to improve image quality Eur J Radiol 99, 131–137.
RkJQdWJsaXNoZXIy MjY0ODMw